← FDA Drug Approvals (Drugs@FDA)
ZYPREXA RELPREVV
NDA · New Drug Application · Sponsor: CHEPLAPHARM · Approved 2009-12-11
Drug application
- FDA Application #
NDA022173- Application type
- New Drug Application
- Brand name
- ZYPREXA RELPREVV
- Generic name
- OLANZAPINE PAMOATE
- Active ingredients
- OLANZAPINE PAMOATE
- Dosage form
- SUSPENSION, EXTENDED RELEASE
- Route
- INTRAMUSCULAR
- Marketing status
- Prescription
- Sponsor
- CHEPLAPHARM
- Manufacturer
- H2-Pharma LLC
- First approval
- 2009-12-11
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown